AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇲🇼
ESOMEPRAZOLE in Malawi
9 products registered with PMRA — 0 active, 9 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ESOZ 20MG TABLET TABLET | PMPB/PL64/53 | — | expired | 31 Mar 2025 |
| MAGPRAZ_20 20MG GASTR RESISTANT TABLET GASTR RESISTANT TABLET | PMPB/PL354/87 | — | expired | 31 Mar 2025 |
| MAGPRAZ_40 40MG GASTRO RESISTANT TABLET GASTRO RESISTANT TABLET | PMPB/PL354/88 | — | expired | 31 Mar 2025 |
| ESOZ 40MG TABLET TABLET | PMPB/PL64/54 | — | expired | 31 Mar 2025 |
| ESOFAG_40 40MG TABLET TABLET | PMPB/PL106/62 | — | expired | 31 Mar 2025 |
| NEXIKEN_40 40MG TABLET TABLET | PMPB/PL373/24 | — | expired | 30 Jun 2018 |
| NEXIKEN_20 20MG TABLET TABLET | PMPB/PL373/23 | — | expired | 30 Jun 2017 |
| ESOFAG_20 20MG TABLETS TABLETS | PMPB/PL106/61 | — | expired | 30 Jun 2016 |
| ESOPEL_20 20MG TABLET TABLET | PMPB/PL161/36 | — | expired | 30 Jun 2013 |
ESOMEPRAZOLE — PMRA Registration Details
PMRA (Malawi) has 9 registered products containing ESOMEPRAZOLE, of which 0 are currently active. Data is sourced directly from the official PMRA drug register and refreshed daily.
Track ESOMEPRAZOLE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.